Monte Rosa Therapeutics, Inc. (GLUE)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
14. 31
+0.37
+2.6542%
After Hours
$
+0.49 +3.4242% 14. 80
1.18B Market Cap
- P/E Ratio
- Div Yield
796,259 Volume
-2.4 Eps
$ 13.94
Previous Close 
Want to track GLUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Monte Rosa Therapeutics, Inc. (GLUE) Statistics
Valuation metrics
Market Cap 1.18B
Enterprise value 1.08B
Trailing P/E (ttm) -6.14
Forward P/E -
PEG ratio 0.75
Price/Sales (ttm) 39.35
Price/Book (mrq) 2.34
Enterprise Value/Revenue 37.53
Enterprise Value/EBITDA -6.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 884.55K
Average volume (90 days) 1.47M
Price summary
52-Week low 4.6
52-Week high 25.77
Beta -
50-Day moving average 21.48
200-Day moving average 18.51
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.61%
Operating margin -6.33%
Operational effectiveness
Return on assets -0.23%
Return on equity -0.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.34
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 9.52%
Book value per share (mrq) 5.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
